Sarissa Capital Management LP Regulus Therapeutics Inc. Transaction History
Sarissa Capital Management LP
- $402 Million
- Q3 2024
A detailed history of Sarissa Capital Management LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Sarissa Capital Management LP holds 185,183 shares of RGLS stock, worth $224,071. This represents 0.07% of its overall portfolio holdings.
Number of Shares
185,183
Previous 185,183
-0.0%
Holding current value
$224,071
Previous $331,000
12.39%
% of portfolio
0.07%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
78Shares Held
56.3MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$15.6 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$7.83 Million0.73% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$6.05 Million1.54% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$5.16 Million1.62% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$4.8 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $17.7M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...